Loading data
INMDNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 370.5 m USD | 394.82 m USD | 492.05 m USD | 454.27 m USD | 357.57 m USD |
| Cost of revenue | 79.53 m USD | 77.75 m USD | 80.71 m USD | 73.49 m USD | 53.59 m USD |
| Gross profit | 290.97 m USD | 317.07 m USD | 411.34 m USD | 380.79 m USD | 303.97 m USD |
| Research and development expense | 13.32 m USD | 13.14 m USD | 13.41 m USD | 12.43 m USD | 9.53 m USD |
| Operating profit | 85.39 m USD | 112.53 m USD | 195.66 m USD | 197.85 m USD | 167.48 m USD |
| Profit before tax | 110.33 m USD | 143.47 m USD | 217.27 m USD | 201.47 m USD | 168 m USD |
| Income tax expense | 16.5 m USD | -37.81 m USD | 19.35 m USD | 39.95 m USD | 2.93 m USD |
| Net income (reported basis) | 93.83 m USD | 181.28 m USD | 197.92 m USD | 161.52 m USD | 164.97 m USD |
| Basic earnings per share | 1.45 USD/share | 2.29 USD/share | 2.37 USD/share | 1.96 USD/share | 2.03 USD/share |
| Diluted earnings per share | 1.43 USD/share | 2.25 USD/share | 2.3 USD/share | 1.89 USD/share | 1.92 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.